导电系统节奏与心房阻塞患者的右心室节奏的前性随机试验; 布拉格CSP试验
Karol Curila1, Jan Mizner1, Jan Morava2
1Department of Cardiology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czechia.
Heart rhythm
|May 24, 2025
概括
导电系统节奏 (CSP) 在严重导电疾病的患者中,与右心室节奏 (RVP) 相比,左心室喷射率 (LVEF) 的下降较小. 这两种节拍方法的临床结果和并发症率都相似.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 导电系统节奏 (CSP) 是传统的右心室节奏 (RVP) 的替代方案,用于胸心病患者.
- 心房导电疾病需要心脏起器植入.
研究的目的:
- 为了比较CSP与RVP的疗效和安全性,在因心房导疾病而被指示植入心脏起器的患者中.
主要方法:
- 一个随机对照试验,涉及249名患者,比较CSP (他的捆或左捆分支区域节奏) 与RVP.
- 主要终点是12个月内左心室喷射分数 (LVEF) 的变化.
- 综合临床终点包括心血管死亡,CRT升级或心力衰竭住院治疗.
主要成果:
- 与RVP相比,CSP的LVEF下降幅度较小 (-2%对-4%,P=0.03).
- 在CSP组中,LVEF显著下降 (≥10%) 较少发生 (5%对16%,P = .01).
- 在CSP和RVP之间的复合临床结果或程序并发症率中没有发现显著差异.
结论:
- 在患有严重导电疾病的患者中,与RVP相比,CSP与左心室射出分数在一年后的更好保存有关.
- 在临床结果和程序安全方面,CSP和RVP都是可比的.
更多相关视频
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
429
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.4K
相关概念视频
Dysrhythmias IV: Characteristics of Bradyarrhythmias
3
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
3
Conduction System of the Heart
825
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
This system relies on the unique properties of nodal and Purkinje cells:...
825
Dysrhythmias VI: Management of Dysrhythmias
3
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3
